Cargando…
The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study
Fibroblast growth factor receptors (FGFRs) are recognized therapeutic targets in cancer. We here describe insights underpinning the impact of mutations on FGFR1 and FGFR3 kinase activity and drug efficacy, using a combination of computational calculations and experimental approaches including cellul...
Autores principales: | Bunney, Tom D., Wan, Shunzhou, Thiyagarajan, Nethaji, Sutto, Ludovico, Williams, Sarah V., Ashford, Paul, Koss, Hans, Knowles, Margaret A., Gervasio, Francesco L., Coveney, Peter V., Katan, Matilda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471147/ https://www.ncbi.nlm.nih.gov/pubmed/26097890 http://dx.doi.org/10.1016/j.ebiom.2015.02.009 |
Ejemplares similares
-
NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 3 in apo state and in complex with inhibitor PD173074
por: Sanfelice, Domenico, et al.
Publicado: (2018) -
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use
por: Patani, Harshnira, et al.
Publicado: (2016) -
Conformational transition of FGFR kinase activation revealed by site-specific unnatural amino acid reporter and single molecule FRET
por: Perdios, Louis, et al.
Publicado: (2017) -
Dynamic Allostery in PLCγ1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR
por: Koss, Hans, et al.
Publicado: (2018) -
Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System
por: Bunney, Tom D., et al.
Publicado: (2018)